Long-lasting wrinkle relaxation with fewer treatments per year.
What Is Daxxify®?
Daxxify is an FDA-approved neuromodulator designed to temporarily improve the appearance of moderate to severe frown lines between the eyebrows. What makes Daxxify different is its longer duration, offering many patients smoother results for significantly more time than traditional neuromodulators.
At Renove Medical Spa, Dr. Michelle Parsons offers Daxxify for patients who want natural-looking wrinkle reduction with fewer maintenance visits.
Why Daxxify Is Different
Daxxify is the first neuromodulator formulated with a synthetic peptide stabilizer rather than human- or animal-derived ingredients. This peptide technology helps stabilize the active ingredient, allowing results to last longer in many patients.
Key benefits of Daxxify include:
-
Longer-lasting results for many patients
-
Fewer treatment sessions per year
-
Natural facial movement preserved
-
FDA-approved for aesthetic use
While most neuromodulators last about 3–4 months, clinical studies show Daxxify has a median duration of approximately 6 months, with some patients experiencing results lasting even longer.
What Daxxify Treats
Daxxify is FDA-approved for:
-
Frown lines between the eyebrows (glabellar lines)
As with other neuromodulators, additional treatment areas may be considered based on clinical judgment and patient goals.
What Results Can You Expect?
-
Visible smoothing of frown lines
-
Natural-looking expression
-
Results that may last 6 months or longer
-
Reduced need for frequent touch-ups
Some patients also report improved skin appearance while their treatment is active.
Daxxify vs. Other Neuromodulators
Daxxify is one of several neuromodulators offered at Renove Medical Spa. While all neuromodulators work by relaxing targeted facial muscles, differences in formulation and duration can make certain options better suited for individual patients.
During your consultation, Dr. Michelle Parsons at Renove Medical Spa will help determine whether Daxxify, Botox, Jeuveau, Xeomin, Dysport, or Letybo is the best option for your needs and lifestyle.
What to Expect from Treatment
-
Quick in-office treatment (about 10–15 minutes)
-
Minimal discomfort
-
No downtime
-
Return to normal activities the same day
Results typically begin within a few days and continue to improve over the first two weeks.
Like 💙 | Share 🔁 | Subscribe 🔔
Follow Renove Med Spa on
Facebook, Instagram, LinkedIn & YouTube
for more transformations and expert insights.
A Word from Dr. Michelle Parsons
“When my snowbird patients asked for a way to keep their results lasting through the winter, I listened. Daxxify® quickly became a favorite—not only because it lasts longer, but because it gives the skin this beautiful, healthy ‘peptide glow.’ My patients love how refreshed they look without feeling overdone, and my year-round clients appreciate fewer visits with longer-lasting confidence.”
— Dr. Michelle Parsons, Renove Medical Spa
Is Daxxify Right for You?
Daxxify may be ideal if you:
-
Want longer-lasting wrinkle reduction
-
Prefer fewer treatment visits per year
-
Want natural results without a frozen look
A consultation with Dr. Michelle Parsons at Renove Medical Spa will determine if Daxxify is the right neuromodulator for you.
Important Safety Information Daxxify is a prescription medication available only through licensed medical professionals. As with all neuromodulators, side effects may include headache, temporary eyelid drooping, or localized injection-site reactions. Serious complications are rare. All risks, benefits, and alternatives will be reviewed prior to treatment.
Largest-ever study of its kind
4,444
Treatments Given
People weren’t just treated once—many were given repeat treatments over time.
2,823
People Treated
More than 2,800 people experienced DAXXIFY®. It was shown to be effective across a diverse group of people with different skin tones and types.
98%
Significant Improvement
In the clinical trials, 98% of people had either no frown lines or mild frown lines when they were evaluated by their injector four weeks after their DAXXIFY® treatment.†
†Per pooled data from two clinical trial studies. 74% had improvement at week 4 per both physician's and patient’s assessments.